Lido Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $100M | Sell |
108,867
-21,808
| -17% | -$22.1M | 0.31% | 53 |
|
|
2025
Q4 | $113M | Buy |
130,675
+1,453
| +1% | +$1.39M | 0.34% | 42 |
|
|
2025
Q3 | $98.6M | Buy |
129,222
+28,452
| +28% | +$21.2M | 0.31% | 45 |
|
|
2025
Q2 | $78.6M | Buy |
100,770
+8,570
| +9% | +$6.66M | 0.31% | 45 |
|
|
2025
Q1 | $76.1M | Buy |
92,200
+29,548
| +47% | +$24.6M | 0.34% | 40 |
|
|
2024
Q4 | $48.4M | Buy |
62,652
+13,428
| +27% | +$11.1M | 0.22% | 59 |
|
|
2024
Q3 | $43.6M | Sell |
49,224
-7,307
| -13% | -$6.57M | 0.22% | 48 |
|
|
2024
Q2 | $51.2M | Buy |
56,531
+16,502
| +41% | +$13.2M | 0.28% | 37 |
|
|
2024
Q1 | $31.1M | Buy |
40,029
+1,895
| +5% | +$1.35M | 0.18% | 58 |
|
|
2023
Q4 | $22.2M | Buy |
38,134
+1,083
| +3% | +$632K | 0.15% | 72 |
|
|
2023
Q3 | $19.9M | Buy |
37,051
+3,098
| +9% | +$1.6M | 0.15% | 70 |
|
|
2023
Q2 | $15.9M | Sell |
33,953
-2,027
| -6% | -$850K | 0.11% | 97 |
|
|
2023
Q1 | $12.4M | Sell |
35,980
-6,910
| -16% | -$2.33M | 0.12% | 106 |
|
|
2022
Q4 | $15.7M | Buy |
42,890
+2,749
| +7% | +$975K | 0.19% | 67 |
|
|
2022
Q3 | $13M | Buy |
40,141
+10,066
| +33% | +$3.19M | 0.16% | 63 |
|
|
2022
Q2 | $9.75M | Sell |
30,075
-4,278
| -12% | -$1.28M | 0.13% | 80 |
|
|
2022
Q1 | $9.84M | Buy |
34,353
+4,500
| +15% | +$1.16M | 0.11% | 98 |
|
|
2021
Q4 | $8.22M | Sell |
29,853
-3,854
| -11% | -$977K | 0.09% | 115 |
|
|
2021
Q3 | $7.79M | Buy |
33,707
+14,450
| +75% | +$3.57M | 0.11% | 104 |
|
|
2021
Q2 | $4.42M | Buy |
19,257
+2,493
| +15% | +$501K | 0.06% | 164 |
|
|
2021
Q1 | $3.13M | Buy |
16,764
+4,378
| +35% | +$856K | 0.05% | 176 |
|
|
2020
Q4 | $2.09M | Buy |
12,386
+3,633
| +42% | +$542K | 0.04% | 210 |
|
|
2020
Q3 | $1.3M | Sell |
8,753
-3,516
| -29% | -$544K | 0.03% | 218 |
|
|
2020
Q2 | $2.01M | Buy |
12,269
+801
| +7% | +$123K | 0.06% | 158 |
|
|
2020
Q1 | $1.59M | Buy |
11,468
+51
| +0.4% | +$7.01K | 0.07% | 164 |
|
|
2019
Q4 | $1.5M | Buy |
11,417
+7,368
| +182% | +$854K | 0.06% | 197 |
|
|
2019
Q3 | $453K | Sell |
4,049
-793
| -16% | -$88.3K | 0.02% | 354 |
|
|
2019
Q2 | $536K | Buy |
4,842
+1,897
| +64% | +$223K | 0.03% | 289 |
|
|
2019
Q1 | $382K | Buy |
2,945
+150
| +5% | +$18.2K | 0.02% | 336 |
|
|
2018
Q4 | $323K | Sell |
2,795
-498
| -15% | -$55.6K | 0.03% | 288 |
|
|
2018
Q3 | $353K | Buy |
3,293
+457
| +16% | +$45.7K | 0.03% | 304 |
|
|
2018
Q2 | $242K | Buy |
+2,836
| New | +$233K | 0.03% | 356 |
|
|
2016
Q3 | – | Sell |
-4,483
| Closed | -$353K | – | 172 |
|
|
2016
Q2 | $353K | Sell |
4,483
-268
| -6% | -$20.2K | 0.11% | 95 |
|
|
2016
Q1 | $342K | Buy |
+4,751
| New | +$359K | 0.12% | 89 |
|
Other funds holding LLY
VCM
VPM
Lido Advisors's LLY Position: Q1 2026 in Review
Lido Advisors reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $22.1M and leaving 108,867 shares worth $100M. The position accounts for 0.31% of the portfolio, ranked #53.
Lido Advisors first reported a position in LLY in Q1 2016 and has held it in 34 quarters since. The position peaked at $113M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Lido Advisors held 108,867 shares of Eli Lilly worth $100M as of Q1 2026.
- Lido Advisors sold 21,808 Eli Lilly shares in Q1 2026, an estimated $22.1M.
- Eli Lilly made up 0.31% of Lido Advisors's portfolio in Q1 2026, its #53 holding.
- Lido Advisors first reported a position in Eli Lilly in Q1 2016 and has held it in 34 quarters since.
- Lido Advisors's Eli Lilly position peaked at $113M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.